[1] Strnad P,Zavadil M,Danes J,et al.The importance of homrmone receptors in benign breast disease[J].Ceska Gynekol,1998,63(1):29-38.
[2] Menssen HD,Siehl JM,Thiel E.Wilms tumor gene (WT1)expression as a panleukemic marker[J].Int J Hematol,2002,76(2):103-109.
[3] Noczynska A,Wasikows R,Myczkowski T.Hypersensitivity of estrogen receptors as a cause of gigantomasty in two girls[J].Pol Merkur Lekarski,2001,11(66):507-509.
[4] 张之南.血液病诊断及疗效标准[M].3 版.北京:科学出版社,2007:103-115.
[5] 蹇在伏,陈方平,解勤之,等.急性白血病患者WT1 基因mRNA 表达研究[J].湖南医科大学学报,1999,24(4):341-342.
[6] Cilloni D,Messa F,Arruga F,et al.Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy [J].Haematologica,2008,93(6):921-924.
[7] Lane SW,Saal R,Negus S.Charaeterisation and prognostic significance of WT-1 gene expression in acute myeloid leukemia(AML) [J].Blood,2006,108(11):2313-2316.
[8] 顾伟英,陈子兴,曹祥山,等.实时定量 RT-PCR 检测急性白血病患者骨髓细胞 WT1 基因表达[J].中华血液学杂志,2004,25(12):728-729.
[9] Gaur GC,Ramadan SM,Cicconi L,et al.Analysis of mutational status,SNP rs16754,and expression levels of Wilms tumor 1(WT1) gene in acute promyelocytic leukemia[J].Ann Hematol,2012,91(12):1855-1860.
[10] KeiholzC,Letsch A,Busse A,et al.A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS[J].Blood,2009,113(26):6541-6545.